BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 21/08/2025

FDA Classifies Liver Iron Concentration Imaging Companion Diagnostic for Deferasirox into Class II

The FDA has classified the liver iron concentration imaging companion diagnostic for deferasirox into Class II, a move aimed at ensuring the device's safety and effectiveness while reducing regulatory burdens and enhancing patient access.

Source: Federal Register — Food and Drug AdministrationOpen original release →